BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9564789)

  • 21. Salvinal, a novel microtubule inhibitor isolated from Salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells.
    Chang JY; Chang CY; Kuo CC; Chen LT; Wein YS; Kuo YH
    Mol Pharmacol; 2004 Jan; 65(1):77-84. PubMed ID: 14722239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum.
    Fennell BJ; Carolan S; Pettit GR; Bell A
    J Antimicrob Chemother; 2003 Apr; 51(4):833-41. PubMed ID: 12654761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhizoxin resistant mutants with an altered beta-tubulin gene in Aspergillus nidulans.
    Takahashi M; Kobayashi H; Iwasaki S
    Mol Gen Genet; 1989 Dec; 220(1):53-9. PubMed ID: 2691873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estramustine depolymerizes microtubules by binding to tubulin.
    Dahllöf B; Billström A; Cabral F; Hartley-Asp B
    Cancer Res; 1993 Oct; 53(19):4573-81. PubMed ID: 8402630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin.
    Hamel E
    Cell Biochem Biophys; 2003; 38(1):1-22. PubMed ID: 12663938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor cells resistant to a microtubule-depolymerizing hemiasterlin analogue, HTI-286, have mutations in alpha- or beta-tubulin and increased microtubule stability.
    Poruchynsky MS; Kim JH; Nogales E; Annable T; Loganzo F; Greenberger LM; Sackett DL; Fojo T
    Biochemistry; 2004 Nov; 43(44):13944-54. PubMed ID: 15518543
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-resistance of nocodazole-resistant mutants of CHO cells toward other microtubule inhibitors: similar mode of action of benzimidazole carbamate derivatives and NSC 181928 and TN-16.
    Gupta RS
    Mol Pharmacol; 1986 Aug; 30(2):142-8. PubMed ID: 3736539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
    Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
    J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and evaluation of alpha-hydroxymethylated conjugated nitroalkenes for their anticancer activity: inhibition of cell proliferation by targeting microtubules.
    Mohan R; Rastogi N; Namboothiri IN; Mobin SM; Panda D
    Bioorg Med Chem; 2006 Dec; 14(23):8073-85. PubMed ID: 16891118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tubulin assembly, taxoid site binding, and cellular effects of the microtubule-stabilizing agent dictyostatin.
    Madiraju C; Edler MC; Hamel E; Raccor BS; Balachandran R; Zhu G; Giuliano KA; Vogt A; Shin Y; Fournier JH; Fukui Y; Brückner AM; Curran DP; Day BW
    Biochemistry; 2005 Nov; 44(45):15053-63. PubMed ID: 16274252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intra-allelic suppression of a mutation that stabilizes microtubules and confers resistance to colcemid.
    Wang Y; Veeraraghavan S; Cabral F
    Biochemistry; 2004 Jul; 43(28):8965-73. PubMed ID: 15248754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction of estramustine with tubulin isotypes.
    Laing N; Dahllöf B; Hartley-Asp B; Ranganathan S; Tew KD
    Biochemistry; 1997 Jan; 36(4):871-8. PubMed ID: 9020786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorescence spectroscopic methods to analyze drug-tubulin interactions.
    Bhattacharyya B; Kapoor S; Panda D
    Methods Cell Biol; 2010; 95():301-29. PubMed ID: 20466142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microtubule alterations and resistance to tubulin-binding agents (review).
    Drukman S; Kavallaris M
    Int J Oncol; 2002 Sep; 21(3):621-8. PubMed ID: 12168109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of apoptosis by the garlic-derived compound S-allylmercaptocysteine (SAMC) is associated with microtubule depolymerization and c-Jun NH(2)-terminal kinase 1 activation.
    Xiao D; Pinto JT; Soh JW; Deguchi A; Gundersen GG; Palazzo AF; Yoon JT; Shirin H; Weinstein IB
    Cancer Res; 2003 Oct; 63(20):6825-37. PubMed ID: 14583480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. beta-Tubulin mutation suppresses microtubule dynamics in vitro and slows mitosis in vivo.
    Sage CR; Davis AS; Dougherty CA; Sullivan K; Farrell KW
    Cell Motil Cytoskeleton; 1995; 30(4):285-300. PubMed ID: 7796459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A radioligand binding assay for antitubulin activity in tumor cells.
    Young DH; Rubio FM; Danis PO
    J Biomol Screen; 2006 Feb; 11(1):82-9. PubMed ID: 16314405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of antimitotic peptides and depsipeptides with tubulin.
    Hamel E
    Biopolymers; 2002; 66(3):142-60. PubMed ID: 12385035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exchangeable GTP binding site of the beta-subunit of brain tubulin in Alzheimer disease.
    Khatoon S; Iqbal K
    Prog Clin Biol Res; 1989; 317():801-7. PubMed ID: 2690125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis for determining the sensitivity of eucaryotes to the antimitotic drug rhizoxin.
    Takahashi M; Matsumoto S; Iwasaki S; Yahara I
    Mol Gen Genet; 1990 Jul; 222(2-3):169-75. PubMed ID: 2274023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.